OrthoPediatrics Corp. Announce Launch of RESPONSE™ Power Scoliosis System
05 5월 2023 - 5:05AM
OrthoPediatrics Corp. (“OrthoPediatrics” or the
“Company”) (Nasdaq: KIDS) a company focused exclusively on
advancing the field of pediatric orthopedics, today announced the
launch of their new Power System for the RESPONSE™ Scoliosis
portfolio. The RESPONSE Power System is a complete portfolio of
instruments for tapping pedicles, inserting screws, and final
tightening of set screws. RESPONSE Power is compatible with
OrthoPediatrics’ entire suite of fusion implant systems, including
RESPONSE 4.5/5.0and RESPONSE 5.5/6.0 fusion systems, and BandLoc –
a sublaminar banding technology. This represents the company’s 49th
system for pediatric orthopedic care.
Greg Odle, President of OrthoPediatrics’
Scoliosis business, commented, “Scoliosis procedures are physically
demanding for surgeons, and can take a toll on their bodies over
time. Our new RESPONSE Power System is designed to provide a more
efficient workflow, easier screw insertion, and reduced effort
required during final tightening of set screws.”
“The new Power System is a great complement to
the RESPONSE Spine portfolio,” said Dr. Timothy Oswald, Pediatric
Orthopedic Surgeon at Wellstar Pediatric Orthopedic Care in
Atlanta. “Being able to efficiently and safely place and secure
implants is critical in fusion procedures, and the new Power System
instrumentation provides significant value over manual
instrumentation to accomplish these steps. One important advantage
is the reduced physical demand on surgeons, which may increase our
longevity in the OR.”
About OrthoPediatrics
Corp.Founded in 2006, OrthoPediatrics is an
orthopedic company focused exclusively on advancing the field of
pediatric orthopedics. As such it has developed the most
comprehensive product offering to the pediatric orthopedic market
to improve the lives of children with orthopedic
conditions. OrthoPediatrics currently markets 49 systems
that serve three of the largest categories within the pediatric
orthopedic market. This product offering spans trauma and
deformity, scoliosis, and sports medicine/other procedures.
OrthoPediatrics’ global sales organization is focused exclusively
on pediatric orthopedics and distributes its products in the
United States and over 70 countries outside the United
States. For more information, please
visit www.orthopediatrics.com.
Investor ContactPhilip Trip
Taylor Gilmartin Groupphilip@gilmartinir.com415-937-5406
OrthoPediatrics (NASDAQ:KIDS)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
OrthoPediatrics (NASDAQ:KIDS)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024